These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 917918)

  • 1. [Long-term administration of verapamil in coronary disease].
    Tkaczewski W; Goch JH; Bala T; Kuklewicz C
    Pol Tyg Lek; 1977 Oct; 32(44):1719-21. PubMed ID: 917918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous verapamil in the treatment of acute coronary insufficiency].
    Albuquerque DC; da Rocha PJ; Albanesi Filho FM; Benchimol CB; Albuquerque EN; Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1979 Apr; 32(4):269-72. PubMed ID: 508109
    [No Abstract]   [Full Text] [Related]  

  • 6. [Verapamil in a single dose, evaluation by means of the ergometric test].
    Pereira MH; Brito FS; Pereira CB; Lion MF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():83-94. PubMed ID: 889475
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of verapamil in long-term treatment of coronary disease, hypertension and functional disorders of the cardiovascular system].
    Tkaczewski W; Goch JH
    Wiad Lek; 1979 Oct; 32(19):1359-62. PubMed ID: 506277
    [No Abstract]   [Full Text] [Related]  

  • 8. [Administration of verapamil and propranolol for 4 years in a patient with aortocoronary bypass].
    Surić-Lambić Lj
    Srp Arh Celok Lek; 1985 Mar; 113(3):269-75. PubMed ID: 3877993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Verapamil in ischemic pain and arrhythmia].
    Waris E
    Duodecim; 1972; 88(20):1223-32. PubMed ID: 5076303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of the treatment of ischemic heart disease with delayed-action verapamil].
    Zharov EI; Styrova TK; Barinov VG; Martynov AI; Galichenko IV; Sedov VP; Vertkin AL
    Klin Med (Mosk); 1991 Aug; 69(8):48-50. PubMed ID: 1791709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmic effectiveness of isoptin in ischemic heart disease in the middle-aged and elderly].
    Korkushko OV; Sarkisov KG; Butenko AG
    Vrach Delo; 1980 Jan; (1):30-5. PubMed ID: 7376578
    [No Abstract]   [Full Text] [Related]  

  • 13. [Verapamil in the treatment of patients with coronary insufficiency].
    Savenkov PM; Doscicin VL; Zarov EI; Arsakuni RO
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1287+. PubMed ID: 4098328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of verapamil on the functional state of the liver in ischemic heart disease].
    Zharov EI; Makeeva LG; Svetova SD; Makarovskiĭ VV; Shafranskiĭ IuA; Vertkina NV
    Sov Med; 1991; (12):10-3. PubMed ID: 1780769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term study with Stenoptin in general practice].
    Kessler H
    Med Welt; 1980 Jan; 31(4):149-51. PubMed ID: 6154224
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.